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Confirmation of an Association Between CTNNB1 
Mutations and Hyperekplexia
Hyperekplexia (OMIM 149400) is a pathology with amplified motor startle reflex to
visual, auditory or tactile stimuli. It is defined by three major clinical symptoms:
excessive startle reflex, stiffness and generalized stiffness following startle. The
consciousness is conserved during the episode. The physiopathology is
characterized by an anomaly in the glycinergic pathway. Mutations of the
inhibitory glycine receptor, localized in postsynaptic membrane of glycinergic and
GABAergic/glycinergic, neurons was identified.
Actually, five genes are involved in hyperekplexia. In 80% of cases, GLRA1 gene
encoding a part of glycine receptor’s α sub-unit is mutated. In the other cases,
SCL6A5 (presynaptic sodium and chloride-dependent glycine transporter 2),
GLRB (postsynaptique β sub-unit), GPHN (gephryn), ARHGEF9 (collybistin)
mutations are implicated. They can be recessive or dominant and related to the





• Unrelated parents (Belgian)
• Unilateral renal agenesis in mother




Weight: 2,725kg (-2 SD). Height: 50cm (-2 SD). OFC: 32,5cm (-3 SD)
3 months
Surgical correction of bilateral congenital ptosis.
4 months OFC: 38,5cm (-2,5 SD)
He presented repeated episodes of generalized hypertonia and hyperextension
with eye revulsion. His parents described uncoordinated movements of the four
limbs after mild stimuli. Investigations confirmed an hyperekplexia. A treatment by
clonazepam was instigated.
6 months OFC: 40cm (-2,5 SD)
Clinical features:
Congenital bilateral ptosis, microcephaly, horizontal palpebral fissures,
impression of epicanthus, ptosis (D>G), thin upper lip, small mouth, axial
hypotonia and peripheral hypertonia.










• Array CGH analysis was normal (arr(1-22)x2,(XY)x1).
• GLRA1, GLRB and SLC6A5 genes analysis revealed no anomaly
(sequencing and MLPA).
• Gene panel analysis for neurodevelopmental disorders identified a de 
novo CTNNB1 mutation c.1796_1799del in the heterozygous state. 
Gene cDNA change Protein change OMIM Protein function
CTNNB1
3p22.1
NM_001904.3(CTNNB1):c. 1796_1799del p.Phe599Cysfs*14 116806 Beta-catenin is an adherens junction protein
Discussion
• Our patient presents a haploinsufficiency syndrome of CTNNB1 gene which is very rare. Actually, less than a hundred cases have been reported in the literature. 
• In addition to microcephaly and hypotonia, all patients present a developmental delay of varying severity. 
• Beta-catenin has a major role in neuronal adhesion and synaptic remodeling.
• CTNNB1 mutation associated with hyperekplexia has been reported once before1.
• By this case, we confirm the association of CTNNB1 mutation with hyperekplexia and extend the genes which should be investigated in this rare pathology.
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